AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AstraZeneca's AI Agent Bet Points to a New Model for Drug Discovery Automation
AstraZeneca is reportedly turning to an AI agent to reduce the time needed for drug discovery. The move suggests the industry is starting to shift from passive prediction tools to more autonomous systems that can plan, search, and iterate across discovery workflows.
AI Agents Promise Time Back for Doctors, but Healthcare Still Has to Earn It
A new wave of AI agents is being marketed as a way to give clinicians time back by handling administrative work and routine interactions. The challenge is proving that these systems reduce burden in real clinical settings rather than simply shifting work elsewhere.
Cleveland Clinic’s Luminai test could help define AI’s role in hospital operations
Cleveland Clinic is testing Luminai to see whether AI can run parts of hospital operations, a sign that the next AI frontier may be administrative execution rather than clinical decision-making. If successful, these tools could tackle the labor-intensive back office that still consumes hospitals at scale.
Verana Health’s AI Agent Shows How Administrative Automation Is Quietly Becoming Healthcare’s First Big AI Win
Verana Health says its new AI agent can improve efficiency and compliance in MIPS submissions, a task that is both time-consuming and high-stakes. The announcement reinforces a broader trend: AI is gaining traction fastest where the work is repetitive, regulated, and expensive to get wrong.
Truveta and Artera Show How AI Agents Could Rewire Colorectal Screening Outreach
Artera's partnership highlights the use of AI agents in colorectal cancer screening outreach, a more operationally grounded use of AI than image interpretation alone. The focus is on getting patients into screening pipelines, not just improving the screening test itself.
Colorectal Cancer Screening Is Emerging as the Next AI Commercial Battleground
New coverage around Truveta and Artera shows AI being aimed at earlier colorectal cancer risk detection and screening outreach. The common thread is a shift from pure detection toward population-level engagement and prevention.
A No-Code Healthcare AI Agent Builder Targets Clinical Workflows
Infinitus has launched Studio, billed as the first healthcare-specific no-code AI agent builder. The move reflects rising demand for configurable automation tools that let non-engineers deploy workflow agents without building custom infrastructure from scratch.
McKinsey Interview Points to the Next Frontier: AI Agents Inside Biology R&D
A McKinsey discussion with Stanford’s James Zou highlights a new phase in life-sciences AI: using agents not just to predict biology, but to orchestrate research work. The shift could move AI from analytic support toward an active operating layer for scientific decision-making.
Shuttle Pharma’s New AI Agent Points to a More Autonomous Lab Software Stack
Shuttle Pharma says its new AI agent is designed for multi-step drug research, highlighting a growing push beyond single-task models toward systems that can coordinate chained scientific workflows. If that approach works, the competitive battleground in biotech AI may shift from prediction accuracy to orchestration and usability.
Microsoft Showcases Yonsei’s AI Agents as Hospitals Push Beyond Clinical Use Cases
Microsoft highlighted Yonsei University Health System’s use of AI agents to improve administrative and support functions. The development reflects a broader industry reality: some of healthcare’s fastest AI gains may come not from diagnosis, but from automating the operational work surrounding care delivery.
Insilico Expands From Models to Workflow With PandaClaw’s Biologist-Facing AI Agents
Insilico Medicine’s PandaClaw launch suggests the next competitive front in AI drug discovery is not just better models, but better interfaces for scientists. By packaging agentic capabilities for working biologists, the company is pushing AI closer to day-to-day experimental decision-making.
AI Agents Are Challenging Drug Discovery’s Step-by-Step Playbook
A new 36Kr report argues that AI agents are beginning to break from traditional sequential problem-solving in drug development, potentially helping teams overcome cognitive blind spots. The bigger story is that biopharma is testing whether agentic systems can do more than automate tasks and instead reshape scientific reasoning itself.
ARPA-H’s FDA-Authorized AI Agents Point to a New Translational Path for Clinical AI
STAT reports that ARPA-H is developing FDA-authorized AI agents that are being tested in clinical trials, a notable escalation from pilot software to regulated clinical tools. The story is significant because it suggests the U.S. innovation ecosystem is starting to build a clearer bridge between experimental AI systems and formal evidence generation.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.